Concepedia

Kathryn Kwant

KK

Statistics

Publications

3

Citations

43

H-Index

3

Active since

2018

Affiliations

Rapt Therapeutics (United States)(Current)

Kathryn Kwant is an author at Rapt Therapeutics (United States) specializing in immunotherapy, cancer immunology, and cancer immunotherapy.

Publications per year

2018–2021

3

Publications

3

Preclinical and Nonclinical Characterization of HPN217: A Tri-Specific T Cell Activating Construct (TriTAC) Targeting B Cell Maturation Antigen (BCMA) for the Treatment of Multiple Myeloma

Che‐Leung Law, Wade H. Aaron, Rick Austin et al. · Blood · 2018 · 19 citations

, , +14

Abstract C033: HPN328: An anti-DLL3 T cell engager for treatment of small cell lung cancer

Wade H. Aaron, Richard J. Austin, Manasi Barath et al. · Molecular Cancer Therapeutics · 2019 · 14 citations

, , +12

Abstract 933: ProTriTAC is a modular and robust T cell engager prodrug platform with therapeutic index expansion observed across multiple tumor targets

Sen Lin, Sony Sotelo Rocha, Kathryn Kwant et al. · Cancer Research · 2021 · 10 citations

, , +17

1–3 of 3